Published in J Clin Microbiol on May 05, 2010
Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun (2011) 1.13
Asymptomatic bacteriuria: when the treatment is worse than the disease. Nat Rev Urol (2011) 1.03
Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine. Infect Immun (2012) 0.83
Molecular characterization of Escherichia coli strains that cause symptomatic and asymptomatic urinary tract infections. J Clin Microbiol (2011) 0.83
Asymptomatic bacteriuria among elderly and middle-aged rural community-dwellers in South-Western Nigeria. Infect Drug Resist (2013) 0.82
The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine. Front Cell Infect Microbiol (2016) 0.81
Control of gene expression at a bacterial leader RNA, the agn43 gene encoding outer membrane protein Ag43 of Escherichia coli. J Bacteriol (2014) 0.78
Virulence and antimicrobial resistance of common urinary bacteria from asymptomatic students of Niger Delta University, Amassoma, Bayelsa State, Nigeria. J Pharm Bioallied Sci (2016) 0.75
The FimH Gene in Uropathogenic Escherichia coli Strains Isolated From Patients With Urinary Tract Infection. Jundishapur J Microbiol (2015) 0.75
Proteus mirabilis biofilm - qualitative and quantitative colorimetric methods-based evaluation. Braz J Microbiol (2015) 0.75
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol (2000) 18.21
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis (2000) 8.85
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.70
The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun (1999) 6.41
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis (1982) 4.37
Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J Bacteriol (1998) 4.33
Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis (1998) 3.81
Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med (1991) 2.91
Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev (2008) 2.45
Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun (1991) 1.86
Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog (2009) 1.83
Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis (1987) 1.80
Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand (1975) 1.76
Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis (2002) 1.70
Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN(E. coli), among Escherichia coli isolates from patients with urosepsis. Infect Immun (2000) 1.68
Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J Infect Dis (2004) 1.59
Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun (2007) 1.57
The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun (2006) 1.53
Meatal colonization and catheter-associated bacteriuria. N Engl J Med (1980) 1.45
Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun (2006) 1.45
Mechanisms of iron acquisition and bacterial virulence. FEMS Microbiol Rev (1990) 1.44
P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patients' characteristics. J Infect Dis (1987) 1.43
Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun (2007) 1.39
P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol (2000) 1.36
Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun (2006) 1.32
Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines. J Infect Dis (1977) 1.29
Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. J Clin Microbiol (1987) 1.27
Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria. Eur J Epidemiol (1996) 1.24
Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol (2000) 1.24
Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microb Pathog (1993) 1.23
Management of catheter-associated urinary tract infection. Curr Opin Infect Dis (2010) 1.19
Functional flexibility of the FimH adhesin: insights from a random mutant library. Infect Immun (2000) 1.18
The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine. Microbiology (2008) 1.18
Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol (2007) 1.16
Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol (2008) 1.15
Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urine. Infect Immun (2006) 1.14
Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology (2006) 1.12
Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents (2006) 1.10
P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol (2001) 1.08
Bacterial interference--is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection? Int J Antimicrob Agents (2006) 1.01
Virulence factors of Escherichia coli isolates from patients with symptomatic and asymptomatic bacteriuria and neuropathic bladders due to spinal cord and brain injuries. J Clin Microbiol (1998) 0.99
Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J Clin Microbiol (2006) 0.99
Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation. FEMS Immunol Med Microbiol (2007) 0.97
Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential. Int J Antimicrob Agents (2007) 0.94
Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis (2008) 0.89
E. coli virulence factors in children with neurogenic bladder associated with bacteriuria. Pediatr Nephrol (2005) 0.82
Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J (2003) 5.78
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med (2008) 3.87
Global gene expression in Escherichia coli biofilms. Mol Microbiol (2003) 3.33
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Clin Infect Dis (2011) 3.06
Development and maturation of Escherichia coli K-12 biofilms. Mol Microbiol (2003) 2.86
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis (2008) 2.39
Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A (2014) 2.20
Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust (2009) 2.16
Further evidence that the IS481 target is suitable for real-time PCR detection of Bordetella pertussis. Pathology (2013) 2.13
Capsule shields the function of short bacterial adhesins. J Bacteriol (2004) 2.04
Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol (2004) 2.03
DSB proteins and bacterial pathogenicity. Nat Rev Microbiol (2009) 1.99
Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One (2011) 1.94
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol (2005) 1.90
Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms. J Med Microbiol (2006) 1.87
Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011. Med J Aust (2011) 1.86
A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. J Infect Dis (2013) 1.76
Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol (2009) 1.75
Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis (2003) 1.68
Novel roles for the AIDA adhesin from diarrheagenic Escherichia coli: cell aggregation and biofilm formation. J Bacteriol (2004) 1.67
A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. Med J Aust (2007) 1.61
Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun (2007) 1.57
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun (2006) 1.53
The TibA adhesin/invasin from enterotoxigenic Escherichia coli is self recognizing and induces bacterial aggregation and biofilm formation. Infect Immun (2005) 1.46
Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol (2004) 1.46
Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun (2006) 1.45
Discovery of an archetypal protein transport system in bacterial outer membranes. Nat Struct Mol Biol (2012) 1.41
Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol (2006) 1.38
UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J Bacteriol (2008) 1.36
MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression. PLoS Pathog (2011) 1.36
Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis (2005) 1.35
EhaA is a novel autotransporter protein of enterohemorrhagic Escherichia coli O157:H7 that contributes to adhesion and biofilm formation. Environ Microbiol (2008) 1.33
Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun (2006) 1.32
Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol (2008) 1.32
Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol (2013) 1.31
Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust (2003) 1.30
Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun (2005) 1.30
Nematode symbiont for Photorhabdus asymbiotica. Emerg Infect Dis (2006) 1.26
Differential expression of the Escherichia coli autoaggregation factor antigen 43. J Bacteriol (2003) 1.26
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol (2010) 1.25
Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol (2009) 1.24
Glycosylation of the self-recognizing Escherichia coli Ag43 autotransporter protein. J Bacteriol (2006) 1.24
Autotransporter proteins: novel targets at the bacterial cell surface. FEMS Microbiol Lett (2007) 1.19
The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine. Microbiology (2008) 1.18
A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics (2010) 1.17
The multi-copper-ion oxidase CueO of Salmonella enterica serovar Typhimurium is required for systemic virulence. Infect Immun (2010) 1.17
Chaperone-usher fimbriae of Escherichia coli. PLoS One (2013) 1.17
Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology (2011) 1.17
The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. Microbiology (2007) 1.16
Self-associating autotransporters, SAATs: functional and structural similarities. Int J Med Microbiol (2006) 1.16
Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol (2007) 1.16
Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol (2008) 1.15
bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates. Antimicrob Agents Chemother (2005) 1.15
Structure and function of DsbA, a key bacterial oxidative folding catalyst. Antioxid Redox Signal (2011) 1.14
Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urine. Infect Immun (2006) 1.14
Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. J Infect Dis (2012) 1.13
UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun (2010) 1.13
Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology (2006) 1.12
Antigen-43-mediated autoaggregation impairs motility in Escherichia coli. Microbiology (2006) 1.12
Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun (2007) 1.12
Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system. J Bacteriol (2002) 1.10
The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet (2013) 1.09
Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell Q Rep (2009) 1.08
Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett (2006) 1.07
Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology (2006) 1.07